Yuki Enoki Selected Research

Infections

6/2023	Optimal therapeutic recommendation for Clostridioides difficile infection in pediatric and adolescent populations: a systematic review and meta-analysis.
5/2023	Fecal pharmacokinetics/pharmacodynamics characteristics of fidaxomicin and vancomycin against Clostridioides difficile infection elucidated by in vivo feces-based infectious evaluation models.
1/2023	Comparison of the efficacy and safety of standard- and high-dose daptomycin: A systematic review and meta-analysis.
1/2023	Differences in Pharmacokinetic/Pharmacodynamic Parameters of Tedizolid Against VRE and MRSA.
3/2022	Efficacy and Safety of Daptomycin versus Vancomycin for Bacteremia Caused by Methicillin-Resistant Staphylococcus aureus with Vancomycin Minimum Inhibitory Concentration > 1 µg/mL: A Systematic Review and Meta-Analysis
1/2022	Target Therapeutic Ranges of Anti-MRSA Drugs, Linezolid, Tedizolid and Daptomycin, and the Necessity of TDM.
1/2022	Impact of rifampicin on the pharmacokinetics of clarithromycin and 14-hydroxy clarithromycin in patients with multidrug combination therapy for pulmonary Mycobacterium avium complex infection.
11/2021	Cefmetazole as an Alternative to Carbapenems Against Extended-Spectrum Beta-Lactamase-Producing Escherichia coli Infections Based on In Vitro and In Vivo Pharmacokinetics/Pharmacodynamics Experiments.
1/2021	Pharmacokinetic/pharmacodynamic evaluation of teicoplanin against Staphylococcus aureus in a murine thigh infection model.
1/2021	Pharmacokinetics/Pharmacodynamics Evaluation of Flomoxef against Extended-Spectrum Beta-Lactamase-Producing Escherichia coli In Vitro and In Vivo in a Murine Thigh Infection Model.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yuki Enoki Research Topics

Disease

12	Infections 06/2023 - 01/2014
7	Neoplasms (Cancer) 05/2024 - 05/2019
7	Clostridium Infections 10/2023 - 11/2018
7	Chronic Renal Insufficiency 10/2023 - 01/2016
6	Poisoning 10/2023 - 10/2021
5	Atrophy 05/2024 - 01/2016
4	Muscular Atrophy (Muscle Atrophy) 01/2023 - 01/2016
3	Pneumonia (Pneumonitis) 07/2023 - 01/2021
3	Bacterial Meningitis 08/2022 - 09/2021
3	Meningitis 08/2022 - 09/2021
3	Acute Kidney Injury (Acute Renal Failure) 12/2021 - 01/2019
3	Sarcopenia 12/2021 - 01/2016
2	Fibrosis (Cirrhosis) 10/2023 - 01/2022
2	Inflammation (Inflammations) 01/2023 - 01/2020
2	Acidosis 01/2023 - 01/2022
2	Sepsis (Septicemia) 01/2023 - 01/2022
2	Thrombocytopenia (Thrombopenia) 11/2022 - 01/2019
2	Rhabdomyolysis 01/2022 - 01/2020
2	Mitochondrial Diseases (Mitochondrial Disease) 12/2021 - 10/2017
2	Invasive Candidiasis 11/2021 - 11/2020
2	Candidemia 07/2021 - 11/2020
2	Secondary Hyperparathyroidism 12/2017 - 01/2017
2	Human Influenza (Influenza) 01/2015 - 01/2014
2	Virus Diseases (Viral Diseases) 01/2015 - 01/2014
2	Lung Injury 01/2015 - 01/2014
1	Cardiotoxicity 05/2024
1	Critical Illness (Critically Ill) 11/2023
1	Edema (Dropsy) 11/2023
1	Diarrhea 10/2023
1	Ureteral Obstruction 10/2023
1	Hepatocellular Carcinoma (Hepatoma) 10/2023
1	Endocarditis 01/2023
1	Weight Loss (Weight Reduction) 01/2023
1	Foreign Bodies (Foreign Body) 01/2023
1	Osteomyelitis 01/2023
1	Kidney Diseases (Kidney Disease) 01/2023
1	Lung Diseases (Lung Disease) 11/2022
1	Bacteremia 03/2022

Drug/Important Bio-Agent (IBA)

10	Vancomycin FDA LinkGeneric 11/2023 - 11/2018
7	Proteins (Proteins, Gene)FDA Link 10/2023 - 01/2014
7	Anti-Bacterial Agents (Antibiotics)IBA 06/2023 - 01/2015
6	AntidotesIBA 10/2023 - 10/2021
6	IndicanIBA 10/2023 - 01/2016
5	AlbuminsIBA 05/2024 - 12/2021
4	Carbon MonoxideIBA 05/2024 - 01/2020
4	MethemoglobinIBA 10/2023 - 10/2021
4	Metronidazole (Metric)FDA LinkGeneric 07/2023 - 11/2018
4	MyostatinIBA 01/2023 - 01/2016
4	Daptomycin FDA Link 01/2023 - 06/2021
4	Cyanides (Isocyanides)IBA 01/2023 - 10/2021
4	EchinocandinsIBA 07/2021 - 06/2020
3	tedizolidIBA 11/2023 - 01/2022
3	Human Serum Albumin FDA LinkGeneric 10/2023 - 01/2014
3	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 10/2023 - 01/2022
3	AST 120IBA 01/2023 - 10/2017
3	Electron Transport Complex IV (Cytochrome c Oxidase)IBA 01/2023 - 10/2021
3	Linezolid (Zyvox)FDA Link 11/2022 - 09/2021
3	Uremic ToxinsIBA 01/2020 - 01/2016
2	Biomarkers (Surrogate Marker)IBA 05/2024 - 01/2022
2	TeicoplaninIBA 10/2023 - 01/2021
2	Hemoglobins (Hemoglobin)IBA 06/2023 - 12/2021
2	Glucose (Dextrose)FDA LinkGeneric 06/2023 - 01/2022
2	FidaxomicinIBA 05/2023 - 11/2022
2	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 08/2022 - 12/2019
2	Cytochrome P-450 CYP3AIBA 01/2022 - 12/2017
2	Therapeutic UsesIBA 01/2022 - 01/2022
2	salicylhydroxamic acid (SHAM)IBA 01/2022 - 10/2017
2	Liposomes (Liposome)IBA 12/2021 - 10/2021
2	NADPH Oxidases (NAD(P)H oxidase)IBA 12/2021 - 01/2020
2	beta-Lactamases (beta-Lactamase)IBA 11/2021 - 01/2021
2	A-factor (Streptomyces)IBA 10/2021 - 12/2019
2	Cystatin CIBA 06/2021 - 01/2021
2	PolyenesIBA 11/2020 - 11/2020
2	Sulfates (Sulfates, Inorganic)IBA 01/2020 - 02/2015
2	Parathyroid Hormone (Parathormone)IBA 12/2017 - 01/2017
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2015 - 01/2014
2	Hydroxyl RadicalIBA 01/2015 - 01/2014
1	Doxorubicin (Adriamycin)FDA LinkGeneric 05/2024
1	CarrageenanIBA 11/2023
1	PowdersIBA 10/2023
1	Transforming Growth Factors (Transforming Growth Factor)IBA 10/2023
1	cefditoren pivoxil (Spectracef)FDA Link 07/2023
1	Messenger RNA (mRNA)IBA 01/2023
1	Charcoal (Charbon)IBA 01/2023
1	Sodium NitriteIBA 01/2023
1	phenyl-2-aminoethyl sulfide (PAES)IBA 01/2023
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2023
1	Apelin ReceptorsIBA 01/2023
1	ApelinIBA 01/2023
1	LigandsIBA 01/2023
1	apelin-13 peptideIBA 01/2023
1	Ceftazidime (Fortum)FDA LinkGeneric 08/2022
1	NivolumabIBA 01/2022
1	2-methylcyclopentadienyl manganese tricarbonyl (MMT)IBA 01/2022

Therapy/Procedure

7	Therapeutics 05/2024 - 11/2018
2	Aftercare (After-Treatment) 10/2023 - 01/2022
2	Nephrectomy 10/2023 - 01/2023
1	Denervation 01/2023
1	Punctures 01/2023
1	Ligation 01/2023